EMA In The Clear Over Transparency In COVID-19 Product Assessments
Ombudsman Says Agency Showed ‘High Transparency Standards’
Executive Summary
The European Ombudsman has closed an inquiry into the European Medicines Agency’s practices with regard to coronavirus vaccines and treatments.